Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings: Supporting material
Phillips, A, Cambiano, V, Nakagawa, F, Magubu, T, Miners, A, Ford, D, Pillay, D, De Luca, A, Lundgren, J and Revill, P.
2014.
Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings: Supporting material.
[Online].
Figshare.
Available from:
https://doi.org/10.6084/m9.figshare.1155223
Phillips, A, Cambiano, V, Nakagawa, F, Magubu, T, Miners, A, Ford, D, Pillay, D, De Luca, A, Lundgren, J and Revill, P.
Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings: Supporting material
[Internet].
Figshare;
2014.
Available from:
https://doi.org/10.6084/m9.figshare.1155223
Phillips, A, Cambiano, V, Nakagawa, F, Magubu, T, Miners, A, Ford, D, Pillay, D, De Luca, A, Lundgren, J and Revill, P
(2014).
Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings: Supporting material.
[Data Collection].
Figshare.
https://doi.org/10.6084/m9.figshare.1155223
Description
Supplementary data to support publication investigating the cost-Effectiveness of HIV Drug Resistance Testing and how it may be used to inform Antiretroviral Therapy in Low Income environments
University College London, University of Zimbabwe, London School of Hygiene & Tropical Medicine, Africa Centre, South Africa, Siena University Hospital, University of Copenhagen, University of York